To do this, we investigated the expression of IDO1 and medium-chain Acyl-CoA Dehydrogenase (ACADM) in primary and metastatic PCa by analyzing gene expression profiles from datasets containing androgen-ablation resistant PCa metastatic samples [55] and normal and tumor adjacent tissues [55, 56]. Here, ACADM is linked to posterior cortical atrophy.